Navigating Pediatric Diabetes, A Comprehensive Review of Current Approaches and Future Perspectives

Navigating Pediatric Diabetes, A Comprehensive Review of Current Approaches and Future Perspectives

R H Agwa^1,2, Warda Othman^1,3, Taher H. Elwan^4,5, Usama Akl⁴, Essam Mady⁶, Abdallah T. Elwan⁷, Ibrahim M. Shatla^8,9

¹Department of internal medicine, Faculty of Medicine, Al Baha University, KSA

²Hepatology and gastroenterology unit, internal medicine department, faculty of medicine, Mansoura university, Egypt

³Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Koum, Egypt

⁴Department of General Surgery, Faculty of Medicine, Al Baha University, KSA

⁵Department of General Surgery, Benha Faculty of Medicine, Benha University, Egypt

⁶Department of Biochemistry, Faculty of Medicine, Al Baha University, KSA.

⁷Student, Faculty of Medicine, Benha University, Egypt

⁸Department of physiology, Faculty of Medicine, Al Baha University, KSA

⁹Department of Physiology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt

DOI: https://doi.org/10.51584/IJRIAS.2024.90226

Received: 21 January 2024; Revised: 16 February 2024; Accepted: 21 February 2024; Published: 21 March 2024

ABSTRACT

This comprehensive review delves into the multifaceted landscape of pediatric diabetes, providing an insightful exploration of current approaches and illuminating future perspectives in the management of this complex condition. The analysis encompasses an in-depth examination of prevalent treatment modalities, including insulin therapy, lifestyle interventions, and emerging technologies. Special attention is given to the unique challenges faced by pediatric patients, considering the dynamic interplay of developmental factors. The review underscores the importance of a holistic approach, integrating medical, nutritional, and psychosocial aspects of care. Furthermore, it sheds light on promising advancements in research and technology that hold the potential to revolutionize the pediatric diabetes landscape. As we navigate the intricate terrain of pediatric diabetes, this review serves as a valuable roadmap, guiding healthcare practitioners, researchers, and caregivers toward enhanced understanding and more effective strategies for improving the lives of young individuals affected by diabetes.

Keyword; Pediatric, Diabetes, Treatment, Modalities, Technology, Advancements

INTRODUCTION

Pediatric diabetesis a common chronic disease in children[1]and stands as a complex and challenging health concern[2],There are an estimated 1.1 million pediatric patients with type 1 diabetes worldwide, and the once rare childhood type 2 diabetes is dangerously on the rise[3] demanding a nuanced and comprehensive approach to its management. As the prevalence of diabetes among children and adolescents continues to rise globally, and the incidence rates of type 1 diabetes in children and adolescents were higher after the start of the COVID-19 pandemic than before the pandemic[4]it becomes increasingly imperative to scrutinize and understand the current approaches employed in its treatment. The management of pediatric diabetes necessitates a unique set of considerations, given the dynamic nature of childhood development and the distinctive challenges posed by this condition in young individuals. Unlike adults, children and adolescents undergoing the trials of growth and maturation require specialized care that addresses the intricate interplay between physiological, psychological, and environmental factors. Thus, a holistic understanding of the current approaches is crucial for healthcare practitioners, researchers, and caregivers to tailor interventions that are not only effective but also sensitive to the specific needs of the pediatric population.

Exploration of established therapeutic modalities

Exploring established therapeutic modalities for pediatric diabetes involves understanding the various treatment approaches and interventions aimed at managing and controlling diabetes in children. Here are key points to consider in this exploration:

Medical Management: Insulin Therapy: The cornerstone of pediatric diabetes management is insulin therapy[5]. Various types of insulin (rapid-acting, short-acting, intermediate-acting, and long-acting) may be prescribed based on the child’s needs. Insulin Delivery Methods: Different delivery methods include insulin injections using syringes, insulin pens, or insulin pumps. Continuous subcutaneous insulin infusion (CSII) through pumps offers precise insulin delivery[6].

Blood Glucose Monitoring: Frequent Monitoring: Regular blood glucose monitoring is crucial to assess the child’s glucose levels and adjust insulin doses accordingly.

Continuous Glucose Monitoring (CGM): CGM systems provide real-time glucose readings and trends, offering better control and flexibility in managing diabetes[7].

Nutritional Therapy: Carbohydrate Counting: Educating families about carbohydrate counting helps in matching insulin doses to the amount of carbohydrates consumed[8].Balanced Diet: Emphasizing a balanced diet rich in fruits, vegetables, whole grains, and lean proteins is essential for overall health and glycemic control.

Physical Activity: Regular Exercise: Encouraging regular physical activity helps improve insulin sensitivity[9] and overall well-being.Individualized Plans: Tailoring exercise plans to the child’s age, preferences, and diabetes management needs is essential.

Education and Support: Diabetes Education Programs: Providing comprehensive education to children and their families about diabetes self-management, including insulin administration, blood glucose monitoring, and recognizing and managing hypoglycemia. Psychosocial Support: Addressing the emotional and psychological aspects of living with diabetes, including support groups and counseling, is crucial[10].

Regular Medical Follow-up: Routine Check-ups: Regular visits to healthcare providers for monitoring growth, development, and overall health, as well as adjustments to the diabetes management plan. Screening for Complications: Periodic screening for diabetes-related complications, such as eye and kidney problems, to detect and manage issues early.

Technological Advances: Artificial Pancreas Systems: Research and adoption of advanced technologies, such as closed-loop[11] or artificial pancreas systems[12], for automated insulin delivery to optimize glycemic control. Telemedicine: Incorporating telemedicine for remote monitoring and consultations, enhancing accessibility to healthcare services.

Research and Clinical Trials: Innovative Therapies: Ongoing research and participation in clinical trials to explore and develop new therapeutic modalities, medications, and treatment approaches for pediatric diabetes.

Transition to Adulthood: Transition Programs: Planning for the transition from pediatric to adult care, ensuring continuity in diabetes management as the child grows older[13].

Family Involvement: Active Participation: Involving the family in decision-making and care planning to create a supportive environment for the child with diabetes.

Counseling Services: Providing family counseling to address the emotional impact and potential challenges associated with managing pediatric diabetes.

The challenges faced by pediatric patients: Managing diabetes in pediatric patients presents unique challenges due to the dynamic interplay of developmental factors. Here are some key challenges outlined in points:

1. Limited Cognitive Ability: Understanding the complexities of diabetes management requires cognitive abilities that may be limited in younger children[14].Difficulty comprehending the long-term consequences of poor blood glucose control.
2. Dependence on Caregivers: Reliance on parents or caregivers for insulin administration, glucose monitoring, and meal planning. Challenges arise when caregivers are not available, leading to disruptions in the daily management routine.
3. Mealtime Variability: Inconsistent eating patterns and preferences common in children can make it challenging to estimate and administer insulin doses accurately. Limited ability to predict when and what a child will eat adds complexity to glycemic control[15].
4. Physical Activity Patterns: Unpredictable activity levels and energy expenditure in children make it difficult to adjust insulin doses appropriately[16].Balancing insulin with spontaneous play or sports can lead to fluctuations in blood glucose levels[17].
5. Changing Insulin Sensitivity: Growth spurts and pubertal changes impact insulin sensitivity, requiring frequent adjustments to insulin doses[18].Hormonal fluctuations during adolescence can result in increased insulin resistance[19].
6. Fear of Injections: Anxiety and fear associated with insulin injections, leading to potential non-compliance or resistance to therapy. Needle phobia can contribute to emotional distress and impact the child’s willingness to participate in their care.
7. Peer and Social Influences: Social pressure and the desire to fit in may lead to non-compliance with treatment plans, especially during adolescence. The need for privacy in diabetes management may conflict with the child’s desire to be like their peers.
8. School Environment: Challenges in coordinating diabetes management at school, including insulin administration, monitoring, and dealing with hypoglycemia. Lack of understanding among teachers and classmates about diabetes can result in stigmatization.
9. Limited Self-Management Skills: Developing age-appropriate self-management skills is a gradual process, and children may struggle with independence in diabetes care. Transitioning from parent-dependent care to self-management poses challenges during adolescence.
10. Psycho social Impact: Coping with the emotional and psychological aspects of living with a chronic condition. Balancing the desire for normalcy with the need for vigilant diabetes management can affect the child’s mental well-being[20].

PERSPECTIVES FROM PEDIATRIC PATIENTS AND THEIR FAMILIES

Experience: Pediatric patients often express feelings of frustration, fear, and uncertainty about managing their diabetes. They may struggle with the demands of daily blood glucose monitoring, insulin administration, and dietary restrictions.Families commonly experience emotional distress and worry about their child’s health and future. They express the need for additional support and resources to navigate the complexities of diabetes management effectively[21]

Challenges: Adherence to treatment plans can be challenging for pediatric patients, especially during adolescence when they seek independence and autonomy. Balancing diabetes care with social activities, school commitments, and peer pressure presents significant challenges.Access to affordable healthcare, including insulin, supplies, and specialized services, is a common concern for families, particularly those facing financial constraints or living in underserved areas[22].

Preferences: Pediatric patients and family’s value personalized care that considers their unique needs, preferences, and cultural background. They appreciate healthcare providers who listen attentively, offer clear explanations, and involve them in decision-making[23]. Technological innovations such as continuous glucose monitoring systems, insulin pumps, and user-friendly mobile apps are preferred for their convenience, accuracy, and ability to empower patients in self-management.

Supportive networks, including peer support groups, online communities, and educational workshops, are highly valued for providing emotional support, practical advice, and a sense of belonging[24].Overall, pediatric patients and their families highlight the importance of holistic, patient-centered care[23] that addresses not only the medical aspects of diabetes management but also the psychosocial and financial challenges they face. By actively engaging with their perspectives and preferences, healthcare practitioners can better tailor interventions, provide appropriate support, and ultimately improve outcomes for pediatric patients living with diabetes[25].

Examples of patient testimonials, qualitative research findings, and community-based initiatives aimed at supporting pediatric diabetes patients:

Patient Testimonial: “Living with pediatric diabetes has been challenging, but with the support of my healthcare team and participating in community events organized by the Clara Barton Diabetes Center,’ I’ve learned to manage my condition better. Meeting other kids like me has made me feel less alone in this journey[26].”

Qualitative Research Findings: A qualitative study conducted by the Soodhana Mohanet all ‘ explored the psychosocial impact of pediatric diabetes on children and their families. Findings revealed that It was also noted that children with mothers who had formal education beyond the 10th grade had better glycemic control[27].

Community-Based Initiatives: study describes the development and feasibility evaluation of a physical activity intervention for children with type 1 diabetes called ‘Steps to Active Kids with Diabetes’ (STAK-D). conclude that STAK-D was feasible and acceptable to children, their parents and healthcare professionals[28]

Patient Testimonial: “Thanks to the Diabetes Center for Children at Children’s Hospital of Philadelphia (CHOP) family immediately started undergoing training to learn more about treating his condition. The Diabetes Center for Children used a coordinated team approach to help his family learn to manage day-to-day life with diabetes.”[29]

Community-Based Initiatives: newly diagnosed pediatric diabetes patients with experienced peer mentors who provide practical advice, emotional support, and encouragement. This initiative not only helps alleviate feelings of isolation but also promotes self-confidence and resilience among young patients[30].

These examples highlight the diverse approaches undertaken to support pediatric diabetes patients, encompassing the voices of patients themselves, research insights, and community-driven initiatives aimed at improving their quality of life.

A holistic approach to pediatric diabetes care, integrating medical, nutritional, and psychosocial aspects, is crucial for achieving optimal health outcomes and enhancing the overall well-being of the child. Here’s a breakdown of the importance of each component and their integration:

Medical Aspect: Glycemic Control: Ensures that blood glucose levels are within the target range to prevent short-term complications and reduce the risk of long-term complications. Medication Management: Addresses insulin therapy, dosage adjustments, and the use of emerging technologies for precise diabetes management. Regular Monitoring: Involves frequent blood glucose testing, HbA1c monitoring, and continuous glucose monitoring to assess the effectiveness of treatment plans.

Nutritional Aspect: Balanced Nutrition: Supports overall health by providing essential nutrients, managing blood glucose levels, and preventing nutritional deficiencies. Carbohydrate Counting: Empowers patients and caregivers to make informed food choices and calculate insulin doses based on carbohydrate content.

Individualized Meal Plans: Tailors dietary recommendations to the child’s preferences, lifestyle, and cultural considerations.

Psycho social Aspect: Emotional Well-being: Addresses the emotional impact of living with a chronic condition, including stress, anxiety, and depression. Family Support: Involves the family in the care process, providing education, resources, and emotional support for both the child and the caregivers. Peer and Social Support: Encourages social interactions, helping children and adolescents feel supported and accepted by their peers.

Integration of Care: Comprehensive Treatment Plans: Develops individualized care plans that consider the unique needs, preferences, and developmental stages of the pediatric patient. Interdisciplinary Collaboration: Involves collaboration among healthcare professionals, including endocrinologists, dietitians, psychologists, and educators, to provide a well-rounded approach to care. Regular Follow-up and Communication: Promotes ongoing communication between healthcare providers, patients, and caregivers to assess progress, address concerns, and make necessary adjustments to the care plan.

Prevention of Complications: Long-Term Health: A holistic approach aims to prevent and manage complications associated with diabetes[31], including cardiovascular issues, kidney disease, and neuropathy. Education on Self-Management: Equips patients with the skills and knowledge to independently manage their diabetes as they transition into adulthood.

Quality of Life: Empowerment: Fosters a sense of empowerment and self-efficacy in pediatric patients, encouraging them to actively participate in their care and make informed decisions. Cultural Competence: Considers cultural and individual variations in beliefs, practices, and dietary preferences to ensure culturally competent and patient-centered care.

Lifestyle Factors: Physical Activity: Integrates physical activity recommendations into the care plan, emphasizing its importance for overall health and glycemic control.

Sleep and Stress Management: Addresses the impact of sleep, stress, and other lifestyle factors on diabetes management, promoting a balanced and healthy lifestyle.

In summary, a holistic approach to pediatric diabetes care recognizes that successful management goes beyond medication and involves addressing the broader aspects of a child’s life. By integrating medical, nutritional, and psycho social components, healthcare providers can tailor care plans to meet the unique needs of each child, ultimately improving adherence, enhancing quality of life, and fostering positive health outcomes.

ADVANCEMENTS IN RESEARCH AND TECHNOLOGY

Several advancements in research and technology have the potential to revolutionize the landscape of pediatric diabetes care, offering improved management, enhanced quality of life, and increased convenience. Here are some key developments:

Closed-Loop Systems (Artificial Pancreas):Advanced Continuous Glucose Monitoring (CGM): Closed-loop systems automatically adjust insulin delivery based on real-time CGM data, reducing the burden of constant monitoring and manual insulin adjustments[32].Improved Glycemic Control: These systems aim to maintain blood glucose levels within the target range, especially during the night and between meals[33].

Advanced Insulin Delivery Systems: Smart Insulin Pens: Devices that track and record insulin doses, providing data to patients and healthcare providers for better adherence monitoring[34].Insulin Patch Pumps: Wearable, discreet devices that deliver insulin through a patch, offering a more user-friendly alternative to traditional pumps and can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications[35].

Gene Therapy and Personalized Medicine:

• Genetic Research: Understanding the genetic factors influencing diabetes risk and response to treatment can lead to personalized therapeutic approaches[36].Also genetic factors play a significant role in influencing the risk of diabetes and can also impact an individual’s response to treatment. Some forms of diabetes result from mutations in a single gene and are known as monogenic diabetes. Examples include maturity-onset diabetes of the young (MODY) and neonatal diabetes[37].Certain human leukocyte antigen (HLA) genes, have demonstrated a significant correlation with an elevated susceptibility to the development of type 1 diabetesin children[38] ,Identifying specific genetic mutations in these cases can guide treatment decisions and help predict the course of the disease
• Pharmaco genomics: Genetic factors can influence an individual’s response to diabetes medications. Pharma cogenomics involves studying how genetic variations impact drug metabolism, efficacy, and side effects[39].
• Tailoring diabetes treatment based on an individual’s genetic profile can optimize drug selection and dosages, improving treatment outcomes.
• Personalized Medicine: Advances in genomic research have paved the way for personalized medicine in diabetes care. Genetic testing and analysis can help identify an individual’s unique genetic makeup and tailor treatment plans accordingly[40].
• Personalized approaches may involve choosing medications that are more likely to be effective for a specific genetic profile, considering lifestyle modifications, and implementing precision medicine strategies.
• Gene Editing Technologies: Emerging gene-editing techniques may offer potential avenues for correcting genetic mutations associated with diabetes[41].

Tele medicine and Digital Health Platforms: Remote Monitoring: Allows healthcare providers to remotely monitor patients’ glucose levels and treatment adherence. Virtual Consultations: Facilitates easier access to healthcare professionals, particularly for families in remote or underserved areas[42].

Data Analytics and Artificial Intelligence (AI): Predictive Analytics: AI algorithms analyze data from CGM, insulin dosages, and other variables to predict trends and patterns, assisting in proactive management[43].Personalized Treatment Algorithms: AI-driven algorithms can tailor treatment plans based on individual patient characteristics and responses.

BIOMEDICAL SENSORS AND WEARABLES

• Smart Fabrics: Wearable fabrics embedded with sensors for non-invasive glucose monitoring, providing continuous data without the need for skin penetration, discomfort ability and risk of infection[44].
• Biometric Devices: Devices that measure physiological parameters, such as sweat glucose levels, offering additional data points for comprehensive monitoring[45].

Islet Cell Transplantation and Beta Cell Replacement:

• Stem Cell Research: Investigating the use of stem cells to generate insulin-producing beta cells for transplantation, potentially offering a long-term solution.The generation of islet-like endocrine clusters from human pluripotent stem cells (hPSCs) has the potential to provide an unlimited source of insulin-producing β cells for the treatment of diabetes[46].
• Encapsulation Technologies: Techniques to protect transplanted islet cells from immune system attacks, reducing the need for immuno suppressive drugs[47].

These advancements collectively contribute to a more patient-centered, technologically advanced, and individualized approach to pediatric diabetes care. As research continues, these innovations hold the potential to significantly improve outcomes and enhance the overall experience for children and adolescents living with diabetes.

To improve the lives of young individuals affected by diabetes:

Comprehensive Support: Establish peer support programs, involve families in care, and provide mental health support to create a supportive network.Collaborate with schools for diabetes management plans, including staff training and awareness campaigns.

Technology Integration: Develop engaging digital health apps and games for educational purposes and utilize technology for medication reminders and lifestyle tracking.

Transition and Independence: Implement structured transition programs for adolescents, fostering gradual independence in self-management skills.

Incentives and Recognition: Create incentive programs to motivate adherence to diabetes management plans and recognize achievements in glycemic control.

Physical Activity Integration: Facilitate participation in physical activities and sports, offering guidance on adjusting insulin doses during activities.

LIMITATIONS

Access to Care Disparities: Limitation: Disparities in access to specialized diabetes care, particularly in underserved communities or rural areas, may exacerbate health outcomes for pediatric patients[48].

Area for Further Research: Investigating interventions to improve access to care, such as tele medicine initiatives, mobile clinics, and community health worker programs, is crucial.Today this technology is a safe choice for patients who cannot go to the doctor or sit at home, especially during a pandemic[48, 49]

Psycho social Challenges: The psycho social impact of diabetes, including depression, anxiety, and diabetes distress, is often overlooked or inadequately addressed in clinical settings Identifying and supporting patients with psycho social problems early in the course of diabetes may promote psycho social well-being and improve their ability to adjust or take adequate responsibility in diabetes self-management[50].

Area for Further Research: Qualitative studies exploring the lived experiences of pediatric patients and families can provide insights into effective psycho social support interventions.

Treatment Adherence and Engagement: Limitation: Maintaining consistent treatment adherence, especially in adolescents, remains a significant challenge[51], leading to sub optimal glycemic control and increased risk of complications[52].

Area for Further Research: Investigating innovative approaches, such as gamification, peer support, and behavioral interventions, to enhance treatment adherence and engagement among pediatric patients is warranted[53].

Impact of Socioeconomic Factors: Limitation: Socioeconomic factors, including income, education level, and access to healthy food options, profoundly influence diabetes management outcomes but are often not adequately addressed in clinical care[54].

Area for Further Research: Longitudinal studies examining the interplay between socioeconomic factors and diabetes outcomes in pediatric populations can inform targeted interventions and policy initiatives[55].

Technological Barriers: Limitation: While technology holds promise for improving diabetes management, disparities in access to and affordability of advanced devices, such as continuous glucose monitors[56] and insulin pumps, persist[57].

Area for Further Research: Research on the effectiveness of low-cost or open-source technological solutions and strategies to mitigate disparities in technology access is needed.

Transition to Adult Care: Limitation: The transition from pediatric to adult diabetes care poses challenges, including gaps in continuity of care, loss of support networks, and differences in care philosophies between pediatric and adult providers[58].

Area for Further Research: Developing and evaluating transition programs that address the unique needs of adolescents, promote self-management skills, and facilitate seamless care transitions is essential.

Cultural Competence and Health Equity: Limitation: Cultural competence and health equity considerations are often insufficiently integrated into pediatric diabetes care, leading to disparities in health outcomes among diverse populations[59].

Area for Further Research: Research on culturally tailored interventions, language access initiatives, and community-based participatory approaches to diabetes care can promote health equity and improve outcomes for all pediatric patients.

while there have been significant advancements and initiatives aimed at supporting pediatric diabetes patients, there are also areas where challenges persist, controversies arise, and further research is needed. Here are some limitations, controversies, and areas requiring further investigation

Long-Term Complications and Quality of Life: Despite advances in diabetes management, the risk of long-term complications such as cardiovascular disease[60], neuropathy[61], and retinopathy remains a concern.

Controversies arise regarding the impact of intensive glycemic control on reducing complications versus the potential risks of hypoglycemia and treatment burden.

In conclusion, fostering an inclusive and comprehensive approach to pediatric diabetes care is essential for improving the lives of young individuals affected by this chronic condition. By integrating medical, psycho social, and technological advancements, healthcare practitioners can create a supportive environment that empowers patients and their families. Initiatives such as peer support programs, educational apps, and cultural competence training contribute to a holistic strategy that addresses the unique needs of each child. Additionally, advocacy for policy changes and participation in research endeavors will further advance the field, ultimately enhancing the overall quality of life for young individuals living with diabetes. Through continuous collaboration, innovation, and a patient-centered focus, the pediatric diabetes landscape can evolve towards more effective, personalized, and compassionate care.

1. Lawrence JM, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C, Marcovina SM, Mayer-Davis EJ, Hamman RF, Dolan L et al: Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017. Jama 2021, 326(8):717-727.
2. Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, Donaghue KC, Magliano DJ, Maniam J, Orchard TJ et al: Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. The lancet Diabetes & endocrinology 2022, 10(10):741-760.
3. Medicine BMC: Diabetes education for better personalized management in pediatric patients. BMC Medicine 2023, 21(1):30.
4. D’Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R: Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Network Open 2023, 6(6):e2321281-e2321281.
5. Rami-Merhar B, Fröhlich-Reiterer E, Hofer SE, Fritsch M: [Diabetes mellitus in childhood and adolescence (Update 2023)]. Wiener klinische Wochenschrift 2023, 135(Suppl 1):106-114.
6. Vanderhoek SM, Wolf RM: Use of continuous subcutaneous insulin infusion (CSII) therapy in pediatric diabetes patients in the perioperative period. Paediatric anaesthesia 2019, 29(9):901-906.
7. Lee GS, Lupsa BC: Continuous Glucose Monitoring for the Internist. The Medical clinics of North America 2021, 105(6):967-982.
8. Tandon A, Bhowmik E, Ali Z, Tripathi S, Bk A, Chen Y, Dabadghao P, Sudhanshu S, Bhatia V: Basic carbohydrate counting and glycemia in young people with type 1 diabetes in India: A randomised controlled trial. Nutrition 2023:112318.
9. Syeda USA, Battillo D, Visaria A, Malin SK: The importance of exercise for glycemic control in type 2 diabetes. American Journal of Medicine Open 2023, 9:100031.
10. Velázquez-Jurado H, Flores-Torres A, Pérez-Peralta L, Salinas-Rivera E, Valle-Nava MD, Arcila-Martinez D, Hernández-Jiménez S: Cognitive behavioral treatment to improve psychological adjustment in people recently diagnosed with type 2 diabetes: Psychological treatment in type 2 diabetes. Health psychology and behavioral medicine 2023, 11(1):2179058.
11. Kalita D, Mirza KB: InsNET: Accurate Basal and Bolus Insulin Dose Prediction for Closed Loop Diabetes Management. Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual International Conference 2023, 2023:1-4.
12. Ballardini G, Tamadon I, Guarnera D, Al-Haddad H, Iacovacci V, Mariottini F, Ricciardi S, Cucini A, Libera AD, Vistoli F et al: Controlling and powering a fully implantable artificial pancreas refillable by ingestible pills. Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual International Conference 2023, 2023:1-7.
13. Vakharia JD, Stanley TL: Facilitating the transition from paediatric to adult care in endocrinology: a focus on growth disorders. Current opinion in endocrinology, diabetes, and obesity 2023, 30(1):32-43.
14. Streisand R, Monaghan M: Young children with type 1 diabetes: challenges, research, and future directions. Current diabetes reports 2014, 14(9):520.
15. Tully C, Ahrabi-Nejad C, Birch LL, Mackey E, Streisand R: Feasibility of Including Behavioral Feeding Training Within a Parent Intervention for Young Children With Type 1 Diabetes. Journal of clinical psychology in medical settings 2019, 26(2):220-227.
16. Adolfsson P, Taplin CE, Zaharieva DP, Pemberton J, Davis EA, Riddell MC, McGavock J, Moser O, Szadkowska A, Lopez P et al: ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in children and adolescents with diabetes. Pediatric Diabetes 2022, 23(8):1341-1372.
17. Colberg SR, Laan R, Dassau E, Kerr D: Physical activity and type 1 diabetes: time for a rewire?Journal of diabetes science and technology 2015, 9(3):609-618.
18. Plamper M, Gohlke B, Woelfle J, Konrad K, Rohrer T, Hofer S, Bonfig W, Fink K, Holl RW: Interaction of Pubertal Development and Metabolic Control in Adolescents with Type 1 Diabetes Mellitus. Journal of Diabetes Research 2017, 2017:8615769.
19. Chowdhury S: Puberty and type 1 diabetes. Indian journal of endocrinology and metabolism 2015, 19(Suppl 1):S51-54.
20. Theofilou P, Vlastos DD: The Psychological Burden of Families with Diabetic Children: A Literature Review Focusing on Quality of Life and Stress. Children (Basel, Switzerland) 2023, 10(6).
21. Kontoangelos K, Raptis A, Lambadiari V, Economou M, Tsiori S, Katsi V, Papageorgiou C, Martinaki S, Dimitriadis G, Papageorgiou C: Burnout Related to Diabetes Mellitus: A Critical Analysis. Clinical practice and epidemiology in mental health : CP & EMH 2022, 18:e174501792209010.
22. Patel NJ, Datye KA, Jaser SS: Importance of Patient-Provider Communication to Adherence in Adolescents with Type 1 Diabetes. Healthcare (Basel, Switzerland) 2018, 6(2).
23. Hill C, Knafl KA, Santacroce SJ: Family-Centered Care From the Perspective of Parents of Children Cared for in a Pediatric Intensive Care Unit: An Integrative Review. Journal of pediatric nursing 2018, 41:22-33.
24. Kimbell B, Lawton J, Boughton C, Hovorka R, Rankin D: Parents’ experiences of caring for a young child with type 1 diabetes: a systematic review and synthesis of qualitative evidence. BMC pediatrics 2021, 21(1):160.
25. Kwame A, Petrucka PM: A literature-based study of patient-centered care and communication in nurse-patient interactions: barriers, facilitators, and the way forward. BMC Nursing 2021, 20(1):158.
26. Center CBD: https://childrenwithdiabetes.com/diabetes-camps/stories-from-diabetes-camp-clara-barton-camp/.
27. Soodhana Mohan D, HN V, Madegowda RK, Palany R: Psychosocial Factors and the Role of Family in Children with Type 1 Diabetes Mellitus. Dubai Diabetes and Endocrinology Journal 2024, 29(3-4):171-178.
28. Quirk H, Glazebrook C, Blake H: A physical activity intervention for children with type 1 diabetes- steps to active kids with diabetes (STAK-D): a feasibility study. BMC pediatrics 2018, 18(1):37.
29. Philadelphia CsHo: https://www.chop.edu/stories/type-1-diabetes-liam-s-story 
30. Lu Y, Pyatak EA, Peters AL, Wood JR, Kipke M, Cohen M, Sequeira PA: Patient Perspectives on Peer Mentoring: Type 1 Diabetes Management in Adolescents and Young Adults. The Diabetes Educator 2014, 41(1):59-68.
31. Małachowska M, Gosławska Z, Rusak E, Jarosz-Chobot P: The role and need for psychological support in the treatment of adolescents and young people suffering from type 1 diabetes. Frontiers in psychology 2022, 13:945042.
32. Jin X, Cai A, Xu T, Zhang X: Artificial intelligence biosensors for continuous glucose monitoring. Interdisciplinary Materials 2023, 2(2):290-307.
33. Friedman JG CMZ, Szmuilowicz ED, Aleppo G. : Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations. . Pharmgenomics Pers Med 2023;16:263-276 https://doiorg/102147/PGPMS3746632023.
34. Raikar AS, Kumar P, Raikar GS, Somnache SN: Advances and Challenges in IoT-Based Smart Drug Delivery Systems: A Comprehensive Review. Applied System Innovation 2023, 6(4):62.
35. Elian V, Popovici V, Ozon E-A, Musuc AM, Fița AC, Rusu E, Radulian G, Lupuliasa D: Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review. Life 2023, 13(8):1663.
36. Sugandh F, Chandio M, Raveena F, Kumar L, Karishma F, Khuwaja S, Memon UA, Bai K, Kashif M, Varrassi G et al: Advances in the Management of Diabetes Mellitus: A Focus on Personalized Medicine. Cureus 2023, 15(8):e43697.
37. Zhang H, Colclough K, Gloyn AL, Pollin TI: Monogenic diabetes: a gateway to precision medicine in diabetes. The Journal of Clinical Investigation 2021, 131(3).
38. Al-Balushi M, Al-Badi S, Al-Yaarubi S, Al-Riyami H, Al-Shidhani A, Al-Hinai S, Alshirawi A, Hasson S, Said E, Al-Jabri A et al: The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population. Sultan Qaboos University medical journal 2023, 23(1):68-75.
39. Ahmed S, Zhou Z, Zhou J, Chen SQ: Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics, proteomics & bioinformatics 2016, 14(5):298-313.
40. Kannan S, Chellappan DK, Kow CS, Ramachandram DS, Pandey M, Mayuren J, Dua K, Candasamy M: Transform diabetes care with precision medicine. Health Science Reports 2023, 6(11):e1642.
41. Lu X, Zhang M, Li G, Zhang S, Zhang J, Fu X, Sun F: Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases. International journal of molecular sciences 2023, 24(17).
42. Reddy S, Wu CC, José A, Hsieh JL, Rautela SD: Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies. Diabetes care 2023, 41(3):452-457.
43. Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP: Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics 2023, 15(7).
44. Zhang S, Zhao W, Zeng J, He Z, Wang X, Zhu Z, Hu R, Liu C, Wang Q: Wearable non-invasive glucose sensors based on metallic nanomaterials. Materials Today Bio 2023, 20:100638.
45. Smith AA, Li R, Tse ZTH: Reshaping healthcare with wearable biosensors. Scientific Reports 2023, 13(1):4998.
46. Hogrebe NJ, Ishahak M, Millman JR: Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell 2023, 30(5):530-548.
47. Zhou X XZ, You Y, Yang W, Feng B, Yang Y, Li F, Chen J and Gao H: Subcutaneous device-free islet transplantation. . Front Immunol (2023) 14:1287182. doi: 10.3389/fimmu.2023.1287182.
48. Foss R, Fischer K, Lampman MA, Laabs S, Halasy M, Allen SV, Garrison GM, Sobolik G, Bernard M, Sosso J et al: Disparities in Diabetes Care: Differences Between Rural and Urban Patients Within a Large Health System. Annals of family medicine 2023, 21(3):234-239.
49. Haleem A, Javaid M, Singh RP, Suman R: Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sensors international 2021, 2:100117.
50. Kalra S, Jena BN, Yeravdekar R: Emotional and Psychological Needs of People with Diabetes. Indian journal of endocrinology and metabolism 2018, 22(5):696-704.
51. Dabas H, Sarin J, Madhu SV: Insulin Adherence in Adolescents with Type 1 Diabetes Mellitus. Indian journal of endocrinology and metabolism 2023, 27(5):394-397.
52. Gandhi K, Vu BK, Eshtehardi SS, Wasserman RM, Hilliard ME: Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice. Diabetes management (London, England) 2015, 5(6):485-498.
53. Dos Santos TT, Ríos MP, de Medeiros G, Mata Á NS, Silva Junior DDN, Guillen DM, Piuvezam G: Gamification as a health education strategy of adolescents at school: Protocol for a systematic review and meta-analysis. PloS one 2023, 18(11):e0294894.
54. Randväli M, Toomsoo T, Šteinmiller J: The Main Risk Factors in Type 2 Diabetes for Cognitive Dysfunction, Depression, and Psychosocial Problems: A Systematic Review. Diabetology 2024, 5(1):40-59.
55. Lomax KE, Taplin CE, Abraham MB, Smith GJ, Haynes A, Zomer E, Ellis KL, Clapin H, Zoungas S, Jenkins AJ et al: Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models. Frontiers in endocrinology 2023, 14:1178958.
56. Almurashi AM, Rodriguez E, Garg SK: Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases. Journal of the Indian Institute of Science 2023:1-26.
57. Real-World Diabetes Technology: Overcoming Barriers and Disparities. Diabetes Technology & Therapeutics 2023, 25(S1):S-176-S-190.
58. Ouimet F, Fortin J, Bogossian A, Padley N, Chapdelaine H, Racine E: Transitioning from pediatric to adult healthcare with an inborn error of immunity: a qualitative study of the lived experience of youths and their families. Frontiers in immunology 2023, 14:1211524.
59. Dickson CA, Ergun-Longmire B, Greydanus DE, Eke R, Giedeman B, Nickson NM, Hoang L-N, Adabanya U, Payares DVP, Chahin S et al: Health equity in pediatrics: Current concepts for the care of children in the 21st century (Dis Mon). Disease-a-Month 2023:101631.
60. Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, Kashif M, Shahzeen F, Tayyab A, Khan MSM et al: Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways. Cureus 2023, 15(9):e45835.
61. Nabrdalik K, Kwiendacz H, Moos J, Moos Ł, Kulpa J, Brzoza Z, Stompór T, Gumprecht J, Lip GYH: Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project. Current Problems in Cardiology 2023, 48(8):101726.